@techcrunch.com 2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@xconomy.com 5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com 5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@techcrunch.com 8 years ago
Innovation in genomics and the future of medtech